Abstract
The suppressed lymphocyte proliferative responses characteristic of graft-versus-host disease (GVHD) are due, in part, to production of nitric oxide (NO). In order to more fully elucidate the role of NO during GVHD, an NO synthesis inhibitor, aminoguanidine (AG), was administered to unirradiated (C57BL/6J X DBA/2J)F1 mice injected with 5 X 10(7) C57BL/6J splenocytes. Administration of AG resulTed in abrogation of the elevation in serum NO2- + NO3- levels characteristic of GVHD. A significantly increased percentage of splenocytes of host phenotype (H2b/d, B220+, and THY1.2+) and a significantly higher hematocrit value were detected in GVHD animals receiving AG therapy. Additionally, the Con A-induced proliferative response of splenocytes obtained from GVHD mice receiving AG therapy was increased compared with the responses of splenocytes from animals that did not receive AG therapy. Parameters not affected by AG therapy included NO synthesis by recovered peritoneal macrophages, donor antihost cytolytic activity in splenocyte populations, serum GM-CSF levels and long-term engraftment of donor cells. These data indicate that NO may play a role in the destruction of both lymphoid and erythroid host tissue as well as the reduced lym...Continue Reading
References
Mar 1, 1992·Transplantation·J M LangrehrR A Hoffman
Apr 11, 1992·Diabetes·J A CorbettM L McDaniel
Aug 1, 1992·The Journal of Clinical Investigation·J M LangrehrR A Hoffman
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S PicardJ L Witztum
Aug 1, 1992·European Journal of Immunology·P GarsideA M Mowat
May 1, 1991·Transplantation·A XenocostasW S Lapp
Mar 7, 1991·The New England Journal of Medicine·J L Ferrara, H J Deeg
Apr 1, 1991·The Journal of Surgical Research·J E Albina, W L Henry
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Nov 1, 1987·The Journal of Experimental Medicine·P F PiguetP Vassalli
Jun 27, 1986·Science·M BrownleeA Cerami
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Feb 1, 1994·The Journal of Experimental Medicine·J B WeinbergG S Gilkeson
Feb 28, 1994·Biochemical and Biophysical Research Communications·G A JolyR G Kilbourn
Jun 1, 1994·The Journal of Clinical Investigation·A H CrossR G Tilton
May 25, 1994·Biochimica Et Biophysica Acta·N R BastianJ B Hibbs
Jul 1, 1994·Arthritis and Rheumatism·M Stefanovic-RacicC H Evans
Sep 1, 1994·The Journal of Clinical Investigation·F H DurieR J Noelle
Jan 1, 1995·The Journal of Experimental Medicine·N K WorrallT B Ferguson
Mar 16, 1993·European Journal of Pharmacology·T P MiskoM G Currie
Aug 1, 1993·The Journal of Experimental Medicine·N McCartney-FrancisS M Wahl
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A CorbettE R Unanue
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·R BucalaH Vlassara
Sep 1, 1993·The Journal of Clinical Investigation·M S HuijbertsB I Lévy
Jun 1, 1960·British Journal of Pharmacology and Chemotherapy·S E LINDELLH WESTLING
Citations
Jun 18, 1999·Transplantation Proceedings·F H BachC Ferran
Mar 20, 2002·The British Journal of Dermatology·K AsagoeT Akagi
Jan 15, 1997·Transplantation·R A HoffmanR L Simmons
Jun 27, 2000·Transplantation·J M LangrehrP Neuhaus
Feb 3, 1999·Annals of the New York Academy of Sciences·B VanhoveJ P Soulillou
May 26, 1999·American Journal of Respiratory Cell and Molecular Biology·I Y HaddadB R Blazar
Sep 18, 2012·Transplant Immunology·Eun-Kee SongChang-Yeol Yim
Dec 16, 2004·Cellular Immunology·Eun-Kee SongChang-Yeol Yim
Jul 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·David HongoDonald A Cohen